Press
Apr 18 2022 | Posted In: 20/20 Blog, Press
Palo Alto, CA — A Wall Street Journal article on age-related retinal tears and detachments features an interview with Stanford’s Vinit Mahajan MD, PhD, professor of ophthalmology and vice chair for ophthalmology research.
Jun 11 2020 | Posted In: 20/20 Blog, Press
Palo Alto, CA — Despite progressively losing his vision to a genetic retinal degenerative disease, Michael Stone, an athlete and small business owner, is active, optimistic, and determined. He channels his energy into running and biking, teaming up with friends to guide him through these activities...
Jun 8 2020 | Posted In: 20/20 Blog, Press
Palo Alto, Ca — Genetic testing doesn’t always provide a diagnosis, so Vinit Mahajan M.D., Ph.D., professor of ophthalmology at Stanford University, has applied proteomics to better understand disease in his patients.
Proteomics is the large-scale analysis of protein expression, and for over a...
Sep 5 2019 | Posted In: 20/20 Blog, Press
Palo Alto, CA – The Stanford Ophthalmology Department highlighted its clinical, surgical, and research achievements in its first annual report Vision Matters: Imagining the Future. In recent years, the department has grown dramatically doubling its faculty and clinical fellows.
Jun 19 2019 | Posted In: 20/20 Blog, Press
Palo Alto, CA - Vinit Mahajan M.D., Ph.D., Stanford vitreoretinal surgeon and Vice Chair of Research in the department of ophthalmology, was recently featured in the article, “Precision Medicine Will Rely on Proteins, Not Just DNA,” written by MaryAnn Liebert for Genetic Engineering and...
